Join to View Full Profile
9393 Towne Centre DrSte 200San Diego, CA 92121
Phone+1 858-964-5004
Fax+1 858-362-1051
Dr. Royston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1970 - 1972
Johns Hopkins University School of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1971 - 2025
MD State Medical License 1972 - 1977
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1984
Publications & Presentations
PubMed
- 12 citationsTargeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E Brammer, Tatyana A Feldman
Blood Advances. 2023-10-24 - 54 citationsInterleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.Robert E. Sobol, Daniel L. Shawler, C Carson, C. Van Beveren, Dan Mercola
Clinical Cancer Research. 1999-09-01 - 17 citationsCombination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma ModelOliver Dorigo, Daniel L. Shawler, Ivor Royston, Robert E. Sobol, Jonathan S. Berek
Gynecologic Oncology. 1998-11-01
Press Mentions
Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent UpdatesAugust 9th, 2022- From CAR T to Liquid Biopsies: The New Cancer Research Unveiled at Annual ConferenceDecember 16th, 2021
- Viracta Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate UpdatesAugust 12th, 2021
- Join now to see all
Grant Support
- Conference--Moab Immunoconjugates For CancerNational Cancer Institute1998
- 10th International Conference On MOAB ImmunoconjugatesNational Cancer Institute1995
- Monoclonal Antibody Therapy Of B-Cell MalignancyNational Cancer Institute1993–1995
- International Conference On MOAB Immunoconjugates For CANational Cancer Institute1994
- 2nd International Conference On Gene Therapy Of CancerNational Cancer Institute1994
- Conference--Mab Immunoconjugates For CancerNational Cancer Institute1992
- Monoclonal Antibodies In Cancer Detection And TreatmentNational Cancer Institute1991
- Conf On Monoclonal Antibody Immunoconjugates For CancerNational Cancer Institute1991
- Monocional Antibodies In Cancer Detection And TreatmentNational Cancer Institute1990
- 5th International Conference On MOAB ImmunoconjugatesNational Cancer Institute1990
- Monoclonal Antibodies In Cancer Detection And TreatmentNational Cancer Institute1985–1990
- Fourth International Conference On Monoclonal AntibodyNational Cancer Institute1989
- Third International Conference On Monoclonal AntibodyNational Cancer Institute1988
- Second International Conference Of Monoclonal AntibodyNational Cancer Institute1987
- Monoclonal Antibodies To Human B Cell LymphomasNational Cancer Institute1985
- Cell Sorting And Surface Marker Laboratory--CoreNational Cancer Institute1985
- Clinical Evaluation Of Biological Response ModifiersDivision Of Cancer Treatment1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
